Praziquantel and Oltipraz: the treatment of schoolchildren infected withSchistosoma mansoniand/orSchistosoma haematobiumin Gezira, Sudan
- 1 January 1988
- journal article
- clinical trial
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 82 (1) , 53-57
- https://doi.org/10.1080/00034983.1988.11812208
Abstract
Of 111 schoolchildren—all of whom were infected with Schistosoma mansoni and 97 of whom were also infected with S. haematobium—54 were treated with Praziquantel (2 × 20 mg kg−1) and 57 with Oltipraz (2 × l5 mg kg−1). There was no apparent difference between the efficacy of the two drugs. Follow-up studies over the following 12 months indicated that mass chemotherapy of schoolchildren can be expected to reduce the egg output of those treated by almost 100%, but that, unless there is some break in transmission, the egg output may well be as high after 12 months as it was before treatment—at least in the boys. After a round of chemotherapy, retreatment of school-aged boys in an area where transmission is heavy will be necessary six to 12 months later.Keywords
This publication has 3 references indexed in Scilit:
- A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, SudanPathogens and Global Health, 1983
- Oltipraz—Antischistosomal Efficacy in Sudanese Infected with Schistosoma Mansoni *The American Journal of Tropical Medicine and Hygiene, 1982
- Comparison of the Bell technique, a modified Kato thick smear technique, and a digestion method for the field diagnosis of schistosomiasis mansoniJournal of Helminthology, 1976